Thymectomy and muscle autoantibodies in myasthenia gravis;Tymektomi og muskelantistoffer ved myasthenia gravis

Tidsskrift for den Norske Laegeforening

Volumn 124, Issue 5, 2004, Pages 629-631

  Romi, Fredrik ^a   Gilhus, Nils Erik ^a   Aarli, Johan A ^a  

^a Nevrologisk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CHOLINERGIC RECEPTOR; CONNECTIN; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; RYANODINE RECEPTOR;

ADULT; ARTICLE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PROGNOSIS; REMISSION; SAFETY; THYMECTOMY; TREATMENT OUTCOME; TREATMENT PLANNING;

ADOLESCENT; ADULT; AUTOANTIBODIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE PROTEINS; MYASTHENIA GRAVIS; PROTEIN KINASES; RECEPTORS, CHOLINERGIC; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; THYMECTOMY; TREATMENT OUTCOME;

EID: 1542573793     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie OG, Aarli JA. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis. Eur J Neurol 2002; 1: 55-61.
2. Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie OG, Aarli JA. Thymectomy in non-thymoma early-onset myasthenia gravis, in correlation with disease severity and muscle autoantibodies. Eur Neurol 2003; 49: 210-7.
3. Venuta F, Rendina EA, De Giacomo T, Della Rocca G, Antonini G, Ciccione AM et al. Thymectomy for myasthenia gravis: a 27-year experience. Eur J Cardiothorac Surg 1999; 15: 621-5.
4. Gronseth GS, Barohn RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review). Neurology 2000; 55: 7-15.
5. Aarli JA, Stefansson K, Marton LSG, Wollmann RL. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin Exp Immunol 1990; 82: 284-8.
6. Mygland Å, Tysnes OB, Aarli JA, Flood PR, Gilhus NE. Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmatic reticulum. J Neuroimmunol 1992; 37: 1-7.
7. Mygland Å, Aarli JA, Matre R, Gilhus NE. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis. J Neurol Neurosurg Psychiatry 1994; 57: 843-6.
8. Skeie GO, Mygland Å, Aarli JA, Gilhus NE. Titin antibodies in patients with late onset myasthenia gravis: clinical correlations. Autoimmunity 1995; 20: 99-104.
9. Romi F, Skeie GO, Aarli JA, Gilhus NE. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Arch Neurol 2000; 57: 1596-600.
10. Jaretzki A III, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 2000; 55: 16-23.
11. Romi F, Skeie GO, Aarli JA, Gilhus NE. Muscle autoantibodies in subgroups of myasthenia gravis patients. J Neurol 2000; 247: 369-75.
12. Keynes G. The results of thymectomy in myasthenia gravis. BMJ 1949; 2: 611-6.
13. Simpson JA. An evaluation of thymectomy in myasthenia gravis. Brain 1958; 81: 112-4.
14. Perlo VP, Arnason B, Castleman B. The thymus gland in elderly patients with myasthenia gravis. Neurology 1975; 25: 294-5.
15. Frist WH, Thirumalai S, Doehring CB, Merrill WH, Stewart JR, Fenichel GM et al. Thymectomy for the myasthenia gravis patient: factors influencing outcome. Ann Thorac Surg 1994; 57: 334-8.
16. Busch C, Machens A, Pichlmeier U, Emskötter T, Izbicki JR. Long-term outcome and quality of life after thymectomy for myasthenia gravis. Ann Surg 1996; 224: 225-32.
17. Slesak G, Melms A, Gerneth F, Sommer N, Weissert R, Dichgans J. Late-onset myasthenia gravis. Follow-up of 113 patients diagnosed after age 60. Ann NY Acad Sci 1998; 841: 777-80.
18. Müller-Hermelink HK, Marx A, Kirchner T. The pathological basis of thymoma associated myasthenia gravis. Ann NY Acad Sci 1993; 681: 56-65.
19. Willcox N, Vincent A. Myasthenia gravis as an example of organ specific autoimmune disease. I: Bird G, Calvert JE, red. B lymphocytes in human disease. Oxford: Oxford University Press, 1988: 469-506.
20. Myking AO, Skeie GO, Varhaug JE, Andersen KS, Gilhus NE, Aarli JA. The histomorphology of the thymus in late onset, non-thymoma myasthenia gravis. Eur J Neurol 1998; 5: 401-5.